Skanditeks subsidiary CMA Microdialysis AB launches system for continuous bedside glucose monitoring
CMA Microdialysis AB (CMA) today announced the launch of the new CE-approved IView Catheter,
which enables highly accurate tight glycemic control (TGC) in the Intensive Care Unit (ICU).
Skanditek holds 78 percent of it´s subsidiary CMA Microdialysis.
As to the rest, we refer to enclosed press release from CMA Microdialysis AB.
SKANDITEK INDUSTRIFÖRVALTNING AB (publ)
For further information, please contact:
Patrik Tigerschiöld, President and CEO,
telephone +46-8-614 00 20,
Philip Siberg, CEO CMA Microdialysis,
mobil +46 70 790 67 43, e-post email@example.com